
Leveraging AI to Accelerate the Discovery of New Tuberculosis Drug Targets
Prime Highlights: Tuberculosis (TB) continues to affect millions globally, with rising concerns over drug-resistant strains.

Prime Highlights: Tuberculosis (TB) continues to affect millions globally, with rising concerns over drug-resistant strains.

Prime Highlights: Germany’s Merck KGaA is negotiating to acquire U.S. biotech firm SpringWorks Therapeutics, specializing

Prime Highlights: Eli Lilly plans to release late-stage trial data for Retatrutide in 2025, ahead

Key highlights: Spotlight on emerging Technologies AI-driven Innovation with Dolffia Industry Whitepaper Release NTT DATA

Key Highlights: • $2.5 Million Grant to Expand Testing in Kenya • Significant Improvement in

Key Highlights: High Performance Infrared Imaging AI-powered Data Evaluation and Multi-modal imaging Versatile and customizable

Prime Highlights: Noel, who has been with UnitedHealthcare since 2007, previously led the Medicare and

Prime Highlights: The company’s stock rose significantly after promising results from an early-stage trial of

Prime Highlights: M42, the Middle East’s largest healthcare company, introduces a new operational structure to

Prime Highlights: The FDA has approved Johnson & Johnson’s Spravato (esketamine) nasal spray for standalone

Prime Highlights: Researchers led by 2024 Nobel Laureate David Baker develop AI-designed proteins that neutralize

Prime Highlights: Washington University research identifies a potential new use for an existing drug. RSK1